As of Mar 26
| -0.25 / -0.43%|
The 3 analysts offering 12-month price forecasts for West Pharmaceutical Services Inc have a median target of 58.00, with a high estimate of 60.00 and a low estimate of 55.00. The median estimate represents a +0.59% increase from the last price of 57.66.
The current consensus among 3 polled investment analysts is to Buy stock in West Pharmaceutical Services Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.